Compounds > oxacillin

Page last updated: 2024-08-17

oxacillin and ranitidine

oxacillin has been researched along with ranitidine in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (14.29)	18.7374
1990's	1 (14.29)	18.2507
2000's	4 (57.14)	29.6817
2010's	1 (14.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Lombardo, F; Obach, RS; Waters, NJ	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Isakov, VA; Yakovenko, EP	1
Agrba, VZ; Grigo'rev, PIa; Iakovenko, EP; Isakov, VA; Shcherbatykh, SI; Stepanov, AV	1

Reviews

1 review(s) available for oxacillin and ranitidine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

2 trial(s) available for oxacillin and ranitidine

Article	Year
Treatment of Helicobacter pylori positive duodenal ulcers. Lancet (London, England), 1990, Sep-22, Volume: 336, Issue:8717 Topics: Campylobacter Infections; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Duodenal Ulcer; Female; Humans; Male; Oxacillin; Randomized Controlled Trials as Topic; Ranitidine	1990
[Experience with the treatment of duodenal ulcer associated with Campylobacter pylori infection by combined use of anti-secretory and antibacterial drugs]. Klinicheskaia meditsina, 1989, Volume: 67, Issue:8 Topics: Adult; Campylobacter Infections; Clinical Trials as Topic; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Female; Humans; Male; Middle Aged; Oxacillin; Ranitidine	1989

Other Studies

4 other study(ies) available for oxacillin and ranitidine

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009